Cassava Sciences, Inc. (SAVA) Stock Forecast & Price Prediction 2024, 2025, 2030, 2040, and 2050
Find Cassava Sciences, Inc. (SAVA) short-term stock forecasts for 2024 by month and long-term price predictions for 2024 to 2050. View past performance, analyst Buy, Sell or Hold ratings, and the latest SAVA stock news and headlines.
1 Month Prediction
$3.98 [0.00%]
3 Month Prediction
$4.78 [20.00%]
6 Month Prediction
$3.03 [-23.96%]
1 Year Prediction
$1.74 [-56.24%]
3 Year Prediction
$1.00 [-74.87%]
5 Year Prediction
$1.00 [-74.87%]
About Cassava Sciences, Inc.
Cassava Sciences, Inc., formerly known as Pain Therapeutics, Inc., is a clinical-stage biopharmaceutical company based in Austin, Texas. Founded in 1998 by Remi Barbier, the company focused on developing pain management therapies. In 2019, it rebranded to Cassava Sciences, shifting its focus to neurodegenerative diseases, particularly Alzheimer's disease.
The company's lead therapeutic candidate was simufilam, an oral drug intended for Alzheimer's treatment. But, in November 2024, Cassava Sciences discontinued its development after Phase III clinical trials failed to show clinical benefit.
In June 2024, Hoau-Yan Wang, a scientific advisor to Cassava Sciences, was charged with fraud related to research on simufilam. Subsequently, in July 2024, CEO Remi Barbier and Senior Vice President Lindsay Burns resigned. In September 2024, the U.S. Securities and Exchange Commission filed fraud charges against the company and its former executives. A proposed settlement included fines totaling $40 million for Cassava Sciences and additional fines for the individuals involved.
As of December 2024, Cassava Sciences has no approved drugs or active clinical trials. The company's future remains uncertain due to the discontinuation of its primary drug candidate and recent legal challenges.
Cassava Sciences, Inc. (SAVA) Historical Performance
IPO Date
Cassava Sciences, Inc. (NASDAQ:SAVA) went public on 14 July, 2000.
Change
Since inception, SAVA has decreased by 94.93%. In the last 5 years, SAVA has fallen from $5.20 to $3.98, a massive -23.46% decrease since 2019.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $85.44 and a low of $2.14.
52 Week Range
$3.65
$42.2
The current price $3.98 is near the 52-week low, which means that the stock is underbought.
SAVA Stock Price History
Based on SAVA stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2018, the SAVA stock has risen from $1.1 - $5.2 to $3.98 - $29.43, which is up 2401.18%. Currently, the stock follows upward trend.
Here, we have calculated stock range of SAVA, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2019 | $1.1 - $5.2 | $1.56 | 83.53 | 1 Year Change |
| 2020 | $2.14 - $11.51 | $5.94 | 598.82 | 2 Year Change |
| 2021 | $19.82 - $85.44 | $52.36 | 6060.0 | 3 Year Change |
| 2022 | $16.33 - $44.25 | $32.35 | 3705.88 | 4 Year Change |
| 2023 | $16.64 - $28.0 | $22.53 | 2550.59 | 5 Year Change |
| 2024 | $3.98 - $29.43 | $21.26 | 2401.18 | 6 Year Change |
SAVA Price Performance
6-Month Performance
SAVA stock dropped by 67.77% in the last six months.
1-Year Performance
The stock has trended downwards by 82.32% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 90.89%.
5-Year Performance
In the last 5 years, the stock has gone down by 23.46%.
According to Cassava Sciences, Inc.'s historical data, below graph gives us the exact picture of how the SAVA stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 3 years and a decline in 2 years.
2019
511.76% ↑
2020
31.15% ↑
2021
540.76% ↑
2022
32.40% ↓
2023
23.80% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Cassava Sciences, Inc. (SAVA) Financials & Stock Analysis
Market Capitalization
Cassava Sciences, Inc. has a market capitalization of $191.48M, which places SAVA in the micro-cap category.
Fundamental Analysis
EPS: $-0.58 (Q3), $-2.32 (1Y)
EPS decreased 546.15% since last quarter, and increased 22.11% since last year.
Net Income: $-27.94 M (Q3), $-97.22 M (1Y)
Net Income decreased 553.99% since last quarter, and increased 27.50% since last year.
Free Cash Flow: $-18.31 M (Q3), $-82.44 M (1Y)
Free Cash Flow increased N/A since last quarter, and increased N/A since last year.
Below, we have listed 12 key indicators for Fundamental analysis for SAVA stock. These indicators help you understand Cassava Sciences, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for SAVA stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $23.25 |
| SMA50 | $26.00 |
| SMA200 | $22.65 |
| RSI | 25.16 |
| Beta | -0.58 |
SMA20 > Current Price
This signals SAVA stock is in short-term bearish momentum.
SMA50 > Current Price
This signals SAVA stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals SAVA stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for SAVA stock is Neutral. Out of all indicators, 4 indicates bullish signals, 4 signals bearish trends and 1 gives neutral trends. The SAVA stock forecast was last updated on 04 December, 2024.
Cassava Sciences, Inc. (SAVA) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $3.98 by the end of 2024, and can reach around $1.75 to $1.42 in 2025. And, the long-term forecast suggests that the stock may further drop to $1.03 - $1.35 in 2027, and $0.88 - $1.09 by 2030. So, the SAVA stock shows a strong upward trend in the next several years.
Short-term SAVA Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2024-12 | $3.98 | 0.0% |
In 2024, the SAVA stock price is expected to fluctuate between $3.98 and $3.98. According to the monthly forecast, the stock could rise to $3.98 by December 2024. If compared to the SAVA's current price, the stock could gain 0.0% by the end of this year.
Long-term SAVA Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2025 | $1.75 | $2.35 | $1.42 | -64.32% |
| 2026 | $1.04 | $0.80 | $0.97 | -75.63% |
| 2027 | $1.03 | $1.21 | $1.35 | -66.08% |
| 2028 | $1.17 | $0.98 | $0.49 | -87.69% |
| 2029 | $0.78 | $0.96 | $1.03 | -74.12% |
| 2030 | $0.88 | $1.21 | $1.09 | -72.61% |
| 2031 | $0.82 | $1.14 | $1.06 | -73.37% |
| 2032 | $1.59 | $0.64 | $0.65 | -83.67% |
| 2033 | $1.25 | $0.58 | $0.87 | -78.14% |
| 2034 | $1.06 | $1.05 | $0.96 | -75.88% |
| 2035 | $1.00 | $0.64 | $0.83 | -79.15% |
| 2036 | $0.62 | $1.04 | $0.72 | -81.91% |
| 2037 | $1.61 | $0.73 | $0.90 | -77.39% |
| 2038 | $1.31 | $1.06 | $0.42 | -89.45% |
| 2039 | $1.03 | $0.98 | $1.03 | -74.12% |
| 2040 | $0.56 | $1.32 | $0.94 | -76.38% |
| 2041 | $0.82 | $1.30 | $1.32 | -66.83% |
| 2042 | $0.85 | $0.58 | $0.74 | -81.41% |
| 2043 | $0.95 | $0.53 | $1.12 | -71.86% |
| 2044 | $1.25 | $1.06 | $0.68 | -82.91% |
| 2045 | $0.81 | $1.26 | $1.00 | -74.87% |
| 2046 | $0.82 | $1.50 | $0.89 | -77.64% |
| 2047 | $0.79 | $1.11 | $1.09 | -72.61% |
| 2048 | $1.20 | $0.92 | $1.08 | -72.86% |
| 2049 | $0.92 | $0.70 | $1.16 | -70.85% |
| 2050 | $1.43 | $0.88 | $1.31 | -67.09% |
Cassava Sciences, Inc. (SAVA) Stock Price Prediction & Forecast 2024 - 2025
At the start of 2024, the SAVA stock was at $23.95. Today, it is trading at $3.98, which is -83.38% decrease from price at the beginning of the year. By the end of this year, you can expect the stock to fall to $3.98 by December 2024 with a -0.00% change.
In early 2025, the SAVA price is expected to descend from $3.98 to $1.75, a change of -56.08% from the current price. By mid-2025, the stock may move up by 34.29% on $2.35 and end the year at $1.42, which is -64.39% compared to today's price.
Cassava Sciences, Inc. (SAVA) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the SAVA stock. During this period, the SAVA's price is forecasted to shift from $1.04 to $1.09, which is 4.81% gain.
In 2026, the stock would possibly open at $1.04, descends to $0.80 by mid-year, and wraps up at $0.97, reflecting a decrease from today's price. Further moving to 2030, the stock can kick off the year at $0.88, drop to $1.21 by mid-year, and finish at $1.09, which is -72.61% change from current price.
Cassava Sciences, Inc. (SAVA) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $0.82 to $0.94, which is up -73.33%
In 2031, we can expect SAVA to fluctuate between $0.82 and $1.06, a shift indicating a -73.33% loss by year-end compared to current price. And Until 2040, SAVA can likely vary from $0.56 to $0.94. By the end of 2040, the stock could record a -76.50% fall from today's stock price.
Cassava Sciences, Inc. (SAVA) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the SAVA stock can see an an upturn from $0.82 to $1.31 in this period. In 2041, the stock can experience a high of $1.30 by mid-year, closing the year at $1.32. This results in a -67.33% decrease from today.
Moving towards the end of 2050, SAVA is projected to open the year at $1.43. The stock may dip to $0.88 during mid-year and finish the year at $1.31. Compared to the stock's current price, this translates to an overall loss of -67.11% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
SAVA : Buy, Sell Or Hold?
Analyst Ratings
Based on 1 analysts, 0 rated as a strong buy, 0 recommended a buy, 1 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.So, according to analyst ratings, the recommendation for SAVA stock is Hold.
Expert Analysis
According to SAVA short-term and long-term forecast, Cassava Sciences, Inc. shares are projected to go down by 67.09%, and reach a value of $1.31 per share by 2050.
As per technical analysis, indicators show a Neutral sentiment, while Fear & Greed Index stands at 57.142857142857146, which signals Greed. Also, SAVA has recorded 10/30 green days, which reflects a 45.45454545454545% positivity rate with a price volatility of 0.17%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that SAVA stock is undervalued. So, Based on SAVA prediction and analysis, it may be the best time to hold SAVA stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "SAVA” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.